Literature DB >> 20099040

New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma.

Ugwuji N Maduekwe1, Gregory Y Lauwers, Carlos Fernandez-Del-Castillo, David L Berger, Charles M Ferguson, David W Rattner, Sam S Yoon.   

Abstract

BACKGROUND: The American Joint Committee on Cancer (AJCC)/International Union Against Cancer (UICC) staging system for gastric cancer incorporates the absolute number of metastatic lymph nodes (N status) and is optimally used when >or=15 nodes are examined. The ratio of metastatic to examined nodes (N ratio) is an effective prognostic tool, but has not been examined in Western patients undergoing primarily D1 lymphadenectomy.
METHODS: Two hundred and fifty seven patients with gastric adenocarcinoma who underwent gastric resection between 1995 and 2005 at our institution were examined. Novel N ratio intervals were determined using the best cutoff approach (Nr0: N ratio = 0 and >or=15 nodes examined; Nr1: 0 <or= N ratio <or= 0.3; Nr2: 0.3 < N ratio <or= 0.7; and Nr3: N ratio > 0.7). Overall survival was examined according to N status and N ratio.
RESULTS: 83% of patients underwent D1 lymphadenectomy with a median of 14 lymph nodes examined. Overall survival stratified by N status was significantly different in patients with <15 nodes examined compared with those with >or=15 nodes examined. When we stratified by N ratio intervals, there was no significant difference in overall survival in patients with <15 versus >or= 15 nodes examined. On multivariate analysis, N ratio but not N status was retained as an independent prognostic factor.
CONCLUSIONS: The use of N status for staging patients undergoing primarily D1 lymphadenectomy results in significant stage migration due to varying numbers of nodes examined. Use of N ratio reduces stage migration and may be a more reliable method of staging these patients.

Entities:  

Mesh:

Year:  2010        PMID: 20099040      PMCID: PMC3785005          DOI: 10.1245/s10434-010-0914-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  38 in total

1.  The superiority of ratio-based lymph node staging in gastric carcinoma.

Authors:  Kentaro Inoue; Yasushi Nakane; Hitoshi Iiyama; Mutsuya Sato; Tatsuya Kanbara; Koji Nakai; Syunichiro Okumura; Keigo Yamamichi; Koshiro Hioki
Journal:  Ann Surg Oncol       Date:  2002 Jan-Feb       Impact factor: 5.344

2.  Metastatic lymph node ratio: a new staging system for gastric cancer.

Authors:  Roberto Persiani; Stefano Rausei; Vincenzo Antonacci; Alberto Biondi; Francesco Casella; Luigi Ciccoritti; Domenico D'Ugo
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

3.  Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian Gastric Cancer Study Group prospective multicenter surgical study.

Authors:  M Degiuli; M Sasako; A Ponti; T Soldati; F Danese; F Calvo
Journal:  J Clin Oncol       Date:  1998-04       Impact factor: 44.544

4.  Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma: Japan clinical oncology group study JCOG 0110-MF.

Authors:  Takeshi Sano; Seiichiro Yamamoto; Mitsuru Sasako
Journal:  Jpn J Clin Oncol       Date:  2002-09       Impact factor: 3.019

5.  Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients.

Authors:  J Rüdiger Siewert; M Feith; M Werner; H J Stein
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

6.  Influence of the number of lymph nodes examined on staging of gastric cancer.

Authors:  H K Lee; H K Yang; W H Kim; K U Lee; K J Choe; J P Kim
Journal:  Br J Surg       Date:  2001-10       Impact factor: 6.939

7.  Outcome of ratio of lymph node metastasis in gastric carcinoma.

Authors:  Etsuro Bando; Yutaka Yonemura; Keizo Taniguchi; Sachio Fushida; Takashi Fujimura; Koichi Miwa
Journal:  Ann Surg Oncol       Date:  2002-10       Impact factor: 5.344

8.  Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.

Authors:  J S Macdonald; S R Smalley; J Benedetti; S A Hundahl; N C Estes; G N Stemmermann; D G Haller; J A Ajani; L L Gunderson; J M Jessup; J A Martenson
Journal:  N Engl J Med       Date:  2001-09-06       Impact factor: 91.245

9.  Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment.

Authors:  Scott A Hundahl; John S Macdonald; Jacqueline Benedetti; Thomas Fitzsimmons
Journal:  Ann Surg Oncol       Date:  2002-04       Impact factor: 5.344

Review 10.  Pathological staging and therapy of oesophageal and gastric cancer.

Authors:  Philip R Debruyne; Scott A Waldman; Stephanie Schulz
Journal:  Expert Opin Pharmacother       Date:  2003-07       Impact factor: 3.889

View more
  24 in total

1.  Superiority of metastatic lymph node ratio to the 7th edition UICC N staging in gastric cancer.

Authors:  Long-Bin Xiao; Jian-Xing Yu; Wen-Hui Wu; Feng-Feng Xu; Shi-Bin Yang
Journal:  World J Gastroenterol       Date:  2011-12-14       Impact factor: 5.742

2.  Lymph Node Ratio as an Alternative to the Number of Metastatic Lymph Nodes for the Prediction of Esophageal Carcinoma Patient Survival.

Authors:  Chen Wei; Wen-Ying Deng; Ning Li; Wei Shen; Chi Zhang; Jia-Yu Liu; Su-Xia Luo
Journal:  Dig Dis Sci       Date:  2015-05-05       Impact factor: 3.199

3.  Prognostic impact of lymph node retrieval and ratio in gastric cancer: a U.S. single center experience.

Authors:  Joyce Wong; Shams Rahman; Nadia Saeed; Hui-Yi Lin; Khaldoun Almhanna; Ravi Shridhar; Sarah Hoffe; Kenneth L Meredith
Journal:  J Gastrointest Surg       Date:  2013-10-16       Impact factor: 3.452

4.  Prognostic assessment of different metastatic lymph node staging methods for gastric cancer after D2 resection.

Authors:  Jia Xu; Yu-Hai Bian; Xin Jin; Hui Cao
Journal:  World J Gastroenterol       Date:  2013-03-28       Impact factor: 5.742

5.  Lymph node ratio is a critical prognostic predictor in gastric cancer treated with S-1 chemotherapy.

Authors:  Akira Ema; Keishi Yamashita; Shinich Sakuramoto; Guoqin Wang; Hiroaki Mieno; Masayuki Nemoto; Tomotaka Shibata; Natsuya Katada; Shiro Kikuchi; Masahiko Watanabe
Journal:  Gastric Cancer       Date:  2013-06-26       Impact factor: 7.370

Review 6.  Evaluation of the seventh AJCC TNM staging system for gastric cancer: a meta-analysis of cohort studies.

Authors:  Jizhun Zhang; Yangbing Zhou; Kewei Jiang; Zhanlong Shen; Yingjiang Ye; Shan Wang
Journal:  Tumour Biol       Date:  2014-04-03

7.  A Nomogram for Predicting Overall Survival of Gastric Cancer Patients with Insufficient Lymph Nodes Examined.

Authors:  Peng-Liang Wang; Fang-Tao Xiao; Bao-Cheng Gong; Fu-Nan Liu; Hui-Mian Xu
Journal:  J Gastrointest Surg       Date:  2017-03-27       Impact factor: 3.452

8.  Is lymphadenectomy a predictor or savior for patients with gastric cancer?

Authors:  Hiroya Takeuchi; Yuko Kitagawa
Journal:  Ann Surg Oncol       Date:  2010-05       Impact factor: 5.344

9.  Radical lymph node dissection and assessment: Impact on gallbladder cancer prognosis.

Authors:  Gui-Jie Liu; Xue-Hua Li; Yan-Xin Chen; Hui-Dong Sun; Gui-Mei Zhao; San-Yuan Hu
Journal:  World J Gastroenterol       Date:  2013-08-21       Impact factor: 5.742

10.  Impact of Lymph Node Ratio and Adjuvant Therapy in Node-Positive Endometrioid Endometrial Cancer.

Authors:  Nicole D Fleming; Pamela T Soliman; Shannon N Westin; Ricardo dos Reis; Mark Munsell; Ann H Klopp; Michael Frumovitz; Alpa M Nick; Kathleen Schmeler; Pedro T Ramirez
Journal:  Int J Gynecol Cancer       Date:  2015-10       Impact factor: 3.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.